Pacific Biosciences of California Inc (PACB) is higher by Monday morning, with the stock gaining 2.15% in pre-market trading to 6.19. PACB's short-term technical score of 7 indicates that the stock has traded less bullishly over the last month than 93% of stocks on the market. In the Medical Devices industry, which ranks 134 out of 146 industries, the stock ranks higher than 15% of stocks. Pacific Biosciences of California Inc has risen 11.19% over the past month, closing at $4.88 on July 11. During this period of time, the stock fell as low as $3.93 and as high as $6.37. PACB has an average analyst recommendation of Buy. The company has an average price target of $18.83.
PACB has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on PACB!